ABSTRACT
INTRODUCTION
Diagnostic paracentesis with ascitic fluid analysis is crucial for the accurate diagnosis and management of ascites. Ascites is associated with several conditions such as chronic liver disease, congestive heart failure, nephrotic syndrome, tuberculosis (TB) and malignancy. 1 Conn and Fessel described a syndrome of infected ascitic fluid in patients with hepatic cirrhosis and named as spontaneous bacterial peritonitis (SBP). SBP is defined as an infection of previously sterile ascitic fluid, without any apparent intra-abdominal source of negative neutrocytic ascites (CNNA). Familiarity on the part of the clinician with ascitic fluid interpretation and with ascitic fluid characteristics in various diseases will increase the chances of controlling ascites early. This study was planned with an objective to identify the bacterial isolates from ascitic fluid and to determine their antibiotic resistance pattern.
MATERIAL AND METHODS
A 
DISCUSSION
Ascites can result from a variety of conditions such as chronic liver disease, malignancy, congestive heart failure, nephrotic syndrome, TB and pancreatic diseases. Cirrhosis of liver accounts for 75% of all patients of ascites followed by malignancy (10-12%) and The ascitic fluid PMN leukocyte concentration is the best index for the rapid presumptive diagnosis of SBP. Recent advances have improved the evaluation of ascitic fluid. Among them are serum albumin/ascites albumin difference, estimation of lactoferrin, PMN counting by automated blood cell counters, using reagent strips and molecular methods i.e., PCR, RFLP and high resolution [9] [10] [11] melting analysis ( HRMA). Familiarity on the part of clinician with ascitic fluid interpretation in various diseases will increase the chances of controlling ascites early. The low concentration of bacteria in ascitic fluid explains the low sensitivity of conventional culture techniques and also explains the low sensitivity of Gram's staining.
In the present study, 20.4% of the samples showed presence of microorganisms on Gram's staining whereas 12 13 Runyon et al and Sainz et al have demonstrated microorganisms in only 6% cases of SBP. The culture positivity of the ascitic fluid in the current study was 4, [14] [15] [16] 37.8% which is comparable to other studies.
Various studies have shown that bedside inoculation of the ascitic fluid into blood culture bottles significantly increases the detection rate of the microorganisms. It also provides quicker identification of the causative 4, [14] [15] [16] organisms.
Optimal sensitivity is achieved when at least 10 ml of ascitic fluid is inoculated into the blood culture bottles.
In the present study, the low culture positivity rate could be because of less incubation time (single blind subculture after 24 hours) and use of different culture media (BHI) instead of multiple blind subculture and use 4 of Columbia broth.
Bacteria isolated from the ascitic fluid in patients with SBP are usually those of the normal intestinal flora. In the present study, Gram negative isolates were isolated more frequently than Gram positive isolates. Among Gram negative isolates, E.coli was most frequently isolated organism followed by Acinetobacter spp., Enterobacter spp., Pseudomonas aeruginosa and Klebsiella oxytoca. Similar findings has also been 4, 16 reported from other studies.
Recent reports have described a change in the bacteriological profile of SBP to Gram positive isolate, especially in patients who were on long-term [17] [18] [19] prophylaxis.
Amongst the Gram positive isolates, S. aureus, Enterococcus faecalis and CoNS were 73.3%, 20% and 6.7% respectively. SBP is only rarely caused by anaerobic organisms or by more than one type of bacteria, so their presence in ascitic fluid should raise suspicion of bacterial peritonitis due to some other cause. It has been suggested that the microbiological causes of SBP and the susceptibility of the causative organisms to antibiotics are changing for several reasons. Since SBP is a serious complication in cirrhotic patients, empirical antibiotic therapy by third generation cephalosporins is usually initiated before the results of the ascitic fluid culture and sensitivity are available. In the present study, among Gram negative isolates, rate of resistance to third generation cephalosporins varies from 50-93%. However Gram negative isolates were found to be relatively sensitive to amikacin and ciprofloxacin. All the strains were found to be sensitive to imipenem. Other studies have recommended use of meropenem, in severe cases as well as in ESBL producing E.coli causing 20 
SBP.
ESBL producing strains have emerged among Enterobacteriaceae such as E. coli and Klebsiella spp., with an estimated prevalence of 25-35% among 17, 21 hospitalized patients.
In the present study ESBLs production was seen in 17.6% of E.coli and 30.5% of 21 Klebsiella spp. isolates. All the ESBL producing strains were multidrug resistant.
All the S.aureus isolates were sensitive to clindamycin and vancomycin but only 90% were sensitive to amoxyclav and ciprofloxacin which is comparable to the 22 study by Ahmad et al.
It is advocated that empiric therapy may be started with imipenem. The drug therapy may be modified later on the basis of subsequent culture and drug susceptibility report. The limitation of the current study was low isolation rate of culture, which could have been increased by multiple subculture and use of better enrichment media.
The current study highlights the bacterial flora responsible for SBP and their susceptibility pattern in northern India. Among Gram negative isolates, E. coli was most common isolate followed by Acinetobacter spp. and among Gram positive isolates, S. aureus was the commonest isolate followed by Enterococcus faecalis. The knowledge of causative organism and their antibiotic resistance profile will help the clinician in choosing appropriate empirical antibiotic therapy in patients with ascites. We also recommend that ESBL producing pathogens should be properly identified and their antibiotic resistance pattern be confirmed and communicated to the physicians for appropriate patient management.
